Enhanced expression of TIGIT but not neuropilin-1 in patients with type 2 diabetes mellitus.
CONCLUSIONS: The expression of TIGIT was enhanced in T2DM and the TIGIT axis could be considered as a new therapeutic purpose for the T2DM.
PMID: 32540486 [PubMed - as supplied by publisher]
Source: Immunology Letters - Category: Allergy & Immunology Authors: Hoseini-Aghdam M, Sheikh V, Eftekharian MM, Rezaeepoor M, Behzad M Tags: Immunol Lett Source Type: research
More News: Allergy & Immunology | Brain | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Neurology